T1	Haplotype	30 45	CYP2D6 * 4 ( MA
T2	Phenotype	107 131	clinical outcomes , were
T3	Phenotype	166 179	S , in either
T4	Chemical	184 200	tamoxifen or non
T5	Chemical	202 218	tamoxifen groups
R1	decreases	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	isAssociatedWith	Arg1:T2	Arg2:T3
R7	isAssociatedWith	Arg1:T2	Arg2:T4
R8	isAssociatedWith	Arg1:T2	Arg2:T5
R9	influences	Arg1:T3	Arg2:T1
R10	decreases	Arg1:T3	Arg2:T2
R11	influences	Arg1:T3	Arg2:T4
R12	influences	Arg1:T3	Arg2:T5
R13	decreases	Arg1:T4	Arg2:T2
R14	influences	Arg1:T4	Arg2:T3
R15	influences	Arg1:T4	Arg2:T5
R16	influences	Arg1:T5	Arg2:T1
R17	decreases	Arg1:T5	Arg2:T2
R18	influences	Arg1:T5	Arg2:T3
R19	influences	Arg1:T5	Arg2:T4
